Concepedia

Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden

Thomas R. Einarson, Colin Vicente, Roman Zilbershtein, Charles Piwko, Christel N. Bø, Hanna Pudas, R. Jensen, M. Hemels

Nordic Journal of Psychiatry · 2013 · 26 citations · 63 references

DOI

Abstract

PP-LAI followed by OLZ-LAI was cost-effective in Sweden for chronic schizophrenia and cost-saving overall to the healthcare system.

References

63

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. · New England Journal of Medicine · 2005 · 5.9K citations · Full text

Clozapine for the Treatment-Resistant Schizophrenic

John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations

Cost of Relapse in Schizophrenia

Peter J. Weiden, Mark Olfson · Schizophrenia Bulletin · 1995 · 674 citations · Full text

Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

Peter J. Weiden, Chris M Kozma, Amy Grogg et al. · Psychiatric Services · 2004 · 621 citations

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

Thomas W. Haywood, Howard M. Kravitz, Linda S. Grossman et al. · American Journal of Psychiatry · 1995 · 493 citations